You are here:

Home
NICE Guidance
Health and social care delivery
Acute and critical care

CerebAir for continuous EEG monitoring in intensive care

Medtech innovation briefing
Reference number: MIB279
Published: 30 November 2021

Download (PDF)

Overview
Summary
The technology
Regulatory information
Equality considerations
Clinical and technical evidence
Expert comments
Expert commentators
Development of this briefing

Regulatory information

CerebAir is a CE-marked class IIa medical device.

Next page Equality considerations Previous page The technology